Clinical Trials Browser

NCT00433511 2026-03-03

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Phase 3 Active not recruiting

4,994 enrolled 11 charts

Breast

Breast Adenocarcinoma

NCT00601900 2025-05-23

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Phase 3 Completed

394 enrolled 11 charts

Breast

Breast Neoplasms

NCT00520975 2025-03-28

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Phase 3 Terminated

96 enrolled 16 charts

Breast

Breast Neoplasms

NCT04732598 2025-02-05

AMBITION

Phase 3 Active not recruiting

280 enrolled

Breast

Breast Neoplasms

NCT01303679 2023-09-06

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Phase 3 Terminated

117 enrolled

Breast

First Line Metastatic Breast Cancer

NCT00028990 2023-06-15

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 3 Completed

722 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT03462251 2023-01-19

RIBBIT

Phase 3 Completed

41 enrolled

Breast

Breast Neoplasms

NCT00785291 2022-10-10

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Phase 3 Completed

799 enrolled 18 charts

Breast

Breast Neoplasms

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase 3 Completed

1,613 enrolled

Breast

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT00625898 2020-09-10

BETH

Phase 3 Terminated

3,509 enrolled

Breast

Breast Neoplasms

NCT01935492 2020-01-18

Stop&Go

Phase 3 Completed

420 enrolled

Breast

Breast Neoplasms

NCT00600340 2019-12-30

TURANDOT

Phase 3 Completed

564 enrolled 72 charts

Breast

Breast Neoplasms

NCT01131195 2019-05-15

Metronomic Therapy in Metastatic Breast Cancer.

Phase 3 Completed

139 enrolled

Breast

Breast Neoplasms

NCT01663727 2019-01-22

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

Phase 3 Completed

481 enrolled 22 charts

Breast

Breast Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast

Breast Neoplasms

NCT00868634 2016-08-31

CARIN

Phase 3 Completed

600 enrolled

Breast

Breast Neoplasms

NCT00567554 2016-02-10

GeparQuinto

Phase 3 Completed

2,600 enrolled

Breast

Breast Neoplasms

NCT00333775 2016-01-27

A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

Phase 3 Completed

736 enrolled 12 charts

Breast

Breast Neoplasms

NCT00391092 2015-08-28

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Phase 3 Completed

424 enrolled 12 charts

Breast

Breast Neoplasms

NCT00929240 2015-03-03

A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Phase 3 Completed

287 enrolled 18 charts

Breast

Breast Neoplasms

NCT00109239 2014-06-18

A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer

Phase 3 Completed

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00262067 2013-12-13

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Phase 3 Unknown

1,237 enrolled 14 charts

Breast

Breast Neoplasms

NCT00281697 2013-07-26

A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)

Phase 3 Completed

684 enrolled 12 charts

Breast

Breast Neoplasms

NCT01200212 2013-05-22

TABEA

Phase 3 Terminated

432 enrolled

Breast

Breast Neoplasms